Co-ordinating the clinical management of imported human cases suspected of being infected with a highly pathogenic virus such as Ebola
Clinical Microbiology and Infection
Xavier de Lamballerie1,2,*
1Aix Marseille Université, IRD French Institute of Research for Development, EHESP French School of Public Health, EPV UMR_D 190 Emergence des Pathologies Virales, Marseille, France
2IHU Méditerranée Infection, APHM Public Hospitals of Marseille, Marseille, France
*Corresponding author mail id: Xavier.De-Lamballerie@univ-amu.fr
In recent years, there have been increasing numbers of alerts for possible imported cases of infection by highly pathogenic viruses (HiPaV).
Striking examples include severe respiratory pathogens (e.g., the SARS or MERS coronavirus)(6), or haemorrhagic fever viruses (e.g., Ebola virus) (3).
Many countries have already implemented disease control measures that include the establishment of specialised facilities such as negative-air pressure isolation rooms for the containment of patients and reference diagnostic laboratories where potentially infectious samples can be safely analysed to provide diagnosis and virus characterisation.
Does it make sense to detect Streptococcus pyogenes during tonsillitis in Europe to prevent acute rheumatic fever? Clinical Practice Guideline for the Management of Chronic Kidney Disease in Patients Infected With HIV: 2014 Update by the HIV Medicine Association of the Infectious Diseases Society of America